Aaron Weitzman

Vistria teams with GHO to capitalize on pharma CDMO expansion

'Through its three business segments – manufacturing, labs and bio storage – Alcami serves as a one-stop shop for the pharma industry,' Vistria's Jon Maschmeyer said.

GTCR’s latest platform involves a familiar face; Corsair and CPPIB bet on comeback in air travel

CPPIB invests in air travel.

GTCR looks to replicate Resonetics' success with new investment Biocoat

GTCR managing director Luke Marker discusses the Chicago PE firm's recent investment in the maker of coatings for medical devices.

Operating challenges lead to opportunities for WCAS; Nordic Capital nets 19x return on The Binding Site

Grant Avenue Capital launches Helios Clinical Research.

Healthcare operating challenges lead to abundant opportunities for WCAS

The opportunity to operate more efficiently is driving increased investment in technology, said Welsh, Carson, Anderson & Stowe's Brian Regan.

Healthcare deals of the week involve Warburg Pincus, Carlyle, Apax, GHO and Vistria

PE deals in healthcare are moving at a brisk clip.

BV aims to help companies fix supply chain problems; Firmament’s Vision Integrated Partners grows

BV backs the supply chain industry.

Opportunities across e-clinical value chain drive GTCR’s formation of Harpula

The Harpula platform is aimed around improving the efficiency of drug research and development.

Public company dislocation marks buying opportunity for private equity; Long Ridge discusses Acqueon

Long Ridge invests in Acqueon.

Public company dislocation marks buying opportunity for private equity; Long Ridge discusses Acqueon